Zdrowie i gospodarka · 19.03.2020
Development of a Shared System Risk Evaluation and Mitigation Strategy; Draft Guidance for Industry; Availability; Reopening of Comment Period
The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice entitled "Development of a Shared System REMS; Draft Guidance for Industry; Availability" that appeared in the Federal Register of June 1, 2018. The Agency is taking this action to allow interested persons additional time to submit comments.